Full Text View
Tabular View
No Study Results Posted
Related Studies
Survey of Thai-Muslim Health Status
This study has been completed.
First Received: June 17, 2008   No Changes Posted
Sponsored by: Mahidol University
Information provided by: Mahidol University
ClinicalTrials.gov Identifier: NCT00701454
  Purpose

The purpose of this study was to determine the prevalence and risk factors of diabetes, hypertension, hyperlipidemia among Thai muslim population aged 35-75 years.


Condition Intervention
Diabetes
Hypertension
Hyperlipidemia
Other: No intervention

Study Type: Observational
Study Design: Ecologic or Community, Cross-Sectional
Official Title: Survey of Thai-Muslim Health Status

Resource links provided by NLM:


Further study details as provided by Mahidol University:

Primary Outcome Measures:
  • prevalence of diabetes, hypertension and hyperlipidemia [ Time Frame: after a 12 h overnight fast ] [ Designated as safety issue: Yes ]

Biospecimen Retention:   Samples Without DNA

Biospecimen Description:

Blood serum


Enrollment: 1488
Study Start Date: September 2005
Study Completion Date: April 2006
Primary Completion Date: April 2006 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
1
Healthy participants (physically and mentally).
Other: No intervention
No intervention

Detailed Description:

This was a cross-sectional study conducted in Bangkok and surrounding provinces. Approximately 1500 participants were enrolled. Study staff interviewed participants on basic demographic data, health status, physical activities, food frequency and 24-hour recall. Anthropometry (body weight, height, hip and waist circumference) and physical assessment (blood pressure)were measured. Ten milliliters of venous blood was drawn by venipuncture after a 12 h overnight fast for determination of fasting plasma glucose (FPG) and blood lipid concentrations (total cholesterol, triglyceride, and HDL-cholesterol). FPG was measured by the enzymatic colorimetric method with glucose oxidase.21 Total cholesterol was determined by the cholesterol oxidase method and serum triglycerides concentration was determined by standardized enzymatic procedures using glycerol phosphate oxidase assay.22, 23 HDL- cholesterol was measured by enzymatic assays.24 LDL cholesterol was calculated according to the method of Friedwald et al.25 All samples were analyzed when internal quality control met the acceptable criteria. Intra-and inter-assay CVs were 2.01% and 3.01% for FPG, 1.87% and 4.24% for total cholesterol, 0.93% and 11.6% for triacylglycerols, and 0.99% and 1.49% for HDL cholesterol, respectively.

  Eligibility

Ages Eligible for Study:   35 Years to 95 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Thai muslim residents in 4 muslim communities in and around Bangkok.

Criteria

Inclusion Criteria:

  • 35 y and older muslim
  • free from severe communicable diseases and mental disorders

Exclusion Criteria:

  • not able to complete the interviews or obtain blood samples for analysis
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00701454

Locations
Thailand, Nakhon Pathom
Institute of Nutrition, Mahidol University
Phuttamonthon, Nakhon Pathom, Thailand, 73170
Sponsors and Collaborators
Mahidol University
Investigators
Study Director: Emorn Wasantwisut, Ph.D. Mahidol University
  More Information

No publications provided

Responsible Party: Institute of Nutrition, Mahidol University ( Nipa Rojroongwasinkul / Assistant Professor )
Study ID Numbers: INMU-2006-01
Study First Received: June 17, 2008
Last Updated: June 17, 2008
ClinicalTrials.gov Identifier: NCT00701454     History of Changes
Health Authority: Thailand: Food and Drug Administration

Keywords provided by Mahidol University:
Thai-muslim
Thai-HALAL
Diabetes
Hypertension
Hyperlipidemia
Metabolic syndrome

Study placed in the following topic categories:
Metabolic Diseases
Hyperlipidemias
Vascular Diseases
Diabetes Mellitus
Metabolic Disorder
Dyslipidemias
Lipid Metabolism Disorders
Hypertension

Additional relevant MeSH terms:
Metabolic Diseases
Hyperlipidemias
Vascular Diseases
Cardiovascular Diseases
Dyslipidemias
Lipid Metabolism Disorders
Hypertension

ClinicalTrials.gov processed this record on September 11, 2009